Indegene Intrinsic Value

INDGN • Healthcare
Current Stock Price
₹520.20
Primary Intrinsic Value
₹374.88
Market Cap
₹2497 Cr
+100.0% Upside
Median Value
₹1040.40
Value Range
₹156 - ₹1251
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

INDGN Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹374.88 ₹299.90 - ₹449.86 -27.9% EPS: ₹17.04, Sector P/E: 22x
Book Value Method asset ₹1090.00 ₹981.00 - ₹1199.00 +109.5% Book Value/Share: ₹545.00, P/B: 2.0x
Revenue Multiple Method revenue ₹1040.40 ₹936.36 - ₹1144.44 +100.0% Revenue/Share: ₹686.67, P/S: 2.0x
EBITDA Multiple Method earnings ₹1040.40 ₹936.36 - ₹1144.44 +100.0% EBITDA: ₹640.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹1250.80 ₹1000.64 - ₹1500.96 +140.4% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹156.06 ₹140.45 - ₹171.67 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹263.27 ₹236.94 - ₹289.60 -49.4% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹1040.40 ₹936.36 - ₹1144.44 +100.0% ROE: 15.6%, P/E Multiple: 14x
Graham Defensive Method conservative ₹457.11 ₹411.40 - ₹502.82 -12.1% EPS: ₹17.04, BVPS: ₹545.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check INDGN share price latest .

Valuation Comparison Chart

INDGN Intrinsic Value Analysis

What is the intrinsic value of INDGN?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Indegene (INDGN) is ₹1040.40 (median value). With the current market price of ₹520.20, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹156.06 to ₹1250.80, indicating ₹156.06 - ₹1250.80.

Is INDGN undervalued or overvalued?

Based on our multi-method analysis, Indegene (INDGN) appears to be trading below calculated value by approximately 100.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 17.33 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.27 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 15.6% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 17.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 0.99x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹442 Cr ₹104 Cr Positive Free Cash Flow 7/10
March 2024 ₹508 Cr ₹345 Cr Positive Free Cash Flow 8/10
March 2023 ₹130 Cr ₹-318 Cr Positive Operating Cash Flow 6/10
March 2022 ₹297 Cr ₹218 Cr Positive Free Cash Flow 8/10
March 2021 ₹172 Cr ₹132 Cr Positive Free Cash Flow 8/10